Nanobiotix (NBTX) Total Liabilities (2023 - 2025)

Nanobiotix's Total Liabilities history runs 3 years deep, the most recent figure standing at $177.2 million for Q4 2025.

• In Q4 2025, Total Liabilities rose 24.58% year-over-year to $177.2 million; the TTM figure through Dec 2025 stood at $177.2 million (up 24.58% YoY), while the FY2025 annual figure was $172.0 million, up 20.91% from the prior year.
• Total Liabilities was $177.2 million for Q4 2025 at Nanobiotix, up from $129.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $177.2 million in Q4 2025 to a low of $103.0 million in Q4 2023.
• Historically, Total Liabilities has averaged $133.7 million across 3 years, with a median of $129.2 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities soared 38.1% in 2024, then increased 10.61% in 2025.
• A 3-year view of Total Liabilities shows it stood at $103.0 million in 2023, then jumped by 38.1% to $142.3 million in 2024, then climbed by 24.58% to $177.2 million in 2025.
• The last three Total Liabilities figures came in at $177.2 million (Q4 2025), $129.2 million (Q2 2025), and $142.3 million (Q4 2024), per Business Quant data.